UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
2 drugmakers to exclusively sell Merck’s diabetic treatment
by Lee Hye-seon
2017-03-27 17:58
US FDA approves 1st treatment for rare skin cancer
by Constance Williams
2017-03-27 16:29
Family-controlled drugmaker draws attention
by Nam Doo-hyun
2017-03-24 11:20
Novartis heart medicine fails in clinical trial
by Marian Chu
2017-03-23 18:25
Dongkook Pharmaceutical spins off contrast medium business
by Lee Hye-seon
2017-03-23 11:52
라인
Tego Science to release new wrinkle cure this year
by Constance Williams
2017-03-22 16:36
Green Cross enjoys sales of over ₩100 billion from flu vaccine
by Lee Hye-seon
2017-03-22 15:45
Korean drug makers struggle in Central Asia
by Nam Doo-hyun
2017-03-17 09:13
Korea to make own version of 'Orange Book'
by Lee Hye-seon
2017-03-16 16:27
Boehringer's antidiabetic drug causes skin disease
by Lee Hye-seon
2017-03-15 17:08
라인
'Botox war' erupts in Korea
by Lee Hye-seon
2017-03-15 16:48
Drug makers boast, with reason, of their ingredient names
by Lee Hye-seon
2017-03-14 11:19
'Amgen Korea will win global recognition soon'
by Park Gi-taek
2017-03-13 18:30
Hanmi Pharmaceutical Group shuffles top management
by Marian Chu
2017-03-13 15:57
Novartis’ leukemia treatment embroiled in efficacy dispute
by Park Gi-taek and Lee Hye-seon
2017-03-13 09:21
라인
Ahngook's plan to enter US, European markets thwarted
by Lee Hye-seon
2017-03-09 14:23
Why some pharms' operating profits plunged last year?
by Nam Doo-hyun
2017-03-08 18:18
Expanded insurance benefits for new lymphoma remedy
by Constance Williams
2017-03-08 10:25
Janssen Korea launches new narcotic painkiller
by Marian Chu
2017-03-06 17:15
Pfizer Korea’s antismoke drug sales soar
by Park Gi-taek
2017-03-06 12:30
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top